Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
基本信息
- 批准号:10892513
- 负责人:
- 金额:$ 30.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-25 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative EfficiencyAmericanAwardBiometryBlack raceBusinessesChild HealthClinical ResearchCollaborationsCommunicationCommunity OutreachDataDecision MakingDelawareDevelopmentEnsureEpidemiologyEvaluationExtramural ActivitiesFundingGoalsGrowthHealthHealthcareHealthcare SystemsInstitutionMedicalMissionOccupational activity of managing financesOsteopeniaPediatric HospitalsPerformancePilot ProjectsPostmenopausePreventionProductivityRegulationResearch DesignResearch InfrastructureResearch PersonnelResourcesResveratrolSouth CarolinaStructureTranslational ResearchTrustUniversitiesWomanWorkbone lossclinical infrastructurecommunity engagementexpectationflexibilityhealth equityhealth inequalitieshealth organizationimplementation facilitationimprovedoperationprogramssoundsuccesstranslational research program
项目摘要
ABSTRACT- ADMINISTRATIVE CORE
The ACCEL CTR Program has successfully met the expectations of this award mechanism by expanding
the capacity for clinical and translational research in Delaware and enhancing our investigators’ ability to
successfully compete for extramural funding in this arena. The success of ACCEL is anchored in the
complementary strengths of the partnership network been built over the past nine years. Our current
network consists of the University of Delaware (lead institution), Christiana Care Health System,
Nemours Children’s Health and Delaware State University—an American, historically Black, public
university. To date, ACCEL has established an exceedingly strong network and infrastructure for clinical
and translational research within Delaware; and, we are now poised and ready to continue our growth
trajectory by building a deeper focus on health equity into our clinical and translational research
infrastructure. The planned components of the ACCEL Program include the Administrative Core and five
other required Cores, including: the Professional Development Core; the Biostatistics, Epidemiology, &
Research Design Core; the Community Engagement & Outreach Core; the Pilot Projects Program, and
the Tracking and Evaluation Core. The overall goal of the Administrative Core is to improve the
efficiency, productivity and impact of the five other Cores so that we are able to successfully meet our
common mission of building clinical and translational research infrastructure that will be sustainable and
ultimately improve the health of Delawareans. We believe that we have a very effective administrative
structure that does not require substantial change. But, in this renewal application, we propose an
exciting new addition to the Administrative Core—a Health Equity Navigator, who will work closely with all
Core leaders to weave the thread of health equity throughout all aspects of the ACCEL program. The
Health Equity Navigator will keep the network focused on health equity as we strengthen our clinical and
translational research infrastructure. The Specific Aims of the Administrative Core are to continue to: (1)
Provide a flexible and efficient administrative and governance structure that enhances the DE-CTR
ACCEL Program’s ability to grow and sustain clinical and translational research programs that address
the most important health care needs of Delawareans and all Americans; (2) Manage the financial and
business operations of the DE-CTR ACCEL Program to ensure operational efficiency, sound fiscal health
of the organization and compliance with all federal, state and local regulations; (3) Enhance and promote
data-informed decision-making, communication and collaboration across all ACCEL components,
participating institutions and other IDeA programs; and (4) Facilitate the implementation of strategic, high-
value initiatives that will enhance the ACCEL Program’s ability to address health inequities and improve
infrastructure for clinical and translational research within the state of Delaware.
抽象的管理核心
加速CTR计划通过扩展成功满足了这种奖励机制的期望
特拉华州临床和翻译研究的能力,并增强了调查人员的能力
成功竞争该领域的校外资金。加速的成功锚定在
在过去的九年中,建立了合作伙伴网络的完全优势。我们的目前
网络由特拉华大学(主要机构)组成,克里斯蒂安娜护理卫生系统,
Nemours儿童健康和特拉华州立大学 - 美国,历史上是黑人,公众
大学。迄今为止,Accel已建立了一个极强的网络和基础设施临床
并翻译了特拉华州的研究;而且,我们现在被中毒,并准备继续我们的成长
通过更深入地关注健康公平的轨迹,进入我们的临床和翻译研究
基础设施。加速计划的计划组件包括行政核心和五个
其他必需的核心,包括:专业发展核心;生物统计学,流行病学和
研究设计核心;社区参与与外展核心;试点项目计划,以及
跟踪和评估核心。行政核心的总体目标是改善
其他五个核心的效率,生产力和影响
建立临床和翻译研究基础设施的共同使命,该基础设施将是可持续和
最终改善了特拉华州的健康。我们相信我们有一个非常有效的行政
不需要实质性变化的结构。但是,在此续签应用中,我们提出了一个
令人兴奋的行政核心新成员 - 健康权益导航员,他将与所有人紧密合作
核心领导者在加入计划的各个方面编织健康公平的线索。这
健康权益导航员将在加强临床和
翻译研究基础设施。行政核心的具体目的是继续:(1)
提供灵活有效的行政和治理结构,以增强DE-CTR
加速计划的发展和维持临床和翻译研究计划的能力,以解决
特拉华州和所有美国人最重要的医疗保健需求; (2)管理财务和
DE-CTR ACCEL计划的业务运营,以确保运营效率,合理的财政健康
组织,遵守所有联邦,州和地方法规; (3)增强和促进
所有加速组件的数据信息的决策,沟通和协作,
参与机构和其他想法计划; (4)有助于实施战略性,高级
价值计划将增强加速计划解决健康不平等和改善的能力
特拉华州内的临床和翻译研究基础设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory E Hicks其他文献
Gregory E Hicks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory E Hicks', 18)}}的其他基金
Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
- 批准号:
10686197 - 财政年份:2022
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10437677 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10885455 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10841849 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10721011 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Admin Core
特拉华州临床和转化研究 ACCEL 计划-管理核心
- 批准号:
10437678 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10372245 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
- 批准号:
10728055 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
- 批准号:
10721012 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10223322 - 财政年份:2013
- 资助金额:
$ 30.16万 - 项目类别:
相似海外基金
Philadelphia Regional Center for Children’s Environmental Health
费城儿童环境健康区域中心
- 批准号:
10534772 - 财政年份:2021
- 资助金额:
$ 30.16万 - 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
- 批准号:
10162753 - 财政年份:2018
- 资助金额:
$ 30.16万 - 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
- 批准号:
10363309 - 财政年份:2018
- 资助金额:
$ 30.16万 - 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
- 批准号:
10361302 - 财政年份:2018
- 资助金额:
$ 30.16万 - 项目类别: